Mylan ROA 2006-2019 | MYL

Current and historical return on assets (ROA) values for Mylan (MYL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Mylan ROA for the three months ending June 30, 2019 was 7.00%.
Mylan ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-06-30 $0.03B $31.82B 0.10%
2019-03-31 $0.24B $31.91B 0.73%
2018-12-31 $0.35B $32.74B 1.05%
2018-09-30 $0.55B $33.46B 1.59%
2018-06-30 $0.46B $33.27B 1.30%
2018-03-31 $0.72B $35.19B 2.01%
2017-12-31 $0.70B $35.81B 1.97%
2017-09-30 $0.87B $35.82B 2.48%
2017-06-30 $0.66B $35.51B 1.87%
2017-03-31 $0.53B $34.27B 1.58%
2016-12-31 $0.48B $34.73B 1.56%
2016-09-30 $0.26B $36.54B 0.93%
2016-06-30 $0.81B $28.84B 3.39%
2016-03-31 $0.81B $22.64B 3.62%
2015-12-31 $0.85B $22.27B 3.84%
2015-09-30 $0.84B $21.32B 4.11%
2015-06-30 $0.91B $22.80B 4.81%
2015-03-31 $0.87B $22.12B 5.06%
2014-12-31 $0.93B $15.82B 6.00%
2014-09-30 $0.92B $15.17B 5.99%
2014-06-30 $0.58B $15.60B 3.92%
2014-03-31 $0.63B $15.36B 4.54%
2013-12-31 $0.62B $15.30B 4.77%
2013-09-30 $0.61B $12.90B 4.95%
2013-06-30 $0.66B $12.21B 5.51%
2013-03-31 $0.62B $11.89B 5.25%
2012-12-31 $0.64B $11.93B 5.44%
2012-09-30 $0.61B $11.71B 5.19%
2012-06-30 $0.55B $11.60B 4.79%
2012-03-31 $0.56B $11.93B 4.81%
2011-12-31 $0.54B $11.60B 4.60%
2011-09-30 $0.41B $11.12B 3.52%
2011-06-30 $0.36B $12.01B 3.08%
2011-03-31 $0.27B $11.88B 2.34%
2010-12-31 $0.22B $11.54B 2.01%
2010-09-30 $0.22B $11.41B 2.05%
2010-06-30 $0.08B $10.60B 0.71%
2010-03-31 $0.08B $10.82B 0.78%
2009-12-31 $0.09B $10.80B 0.89%
2009-09-30 $0.03B $10.76B 0.33%
2009-06-30 $0.26B $10.24B 2.46%
2009-03-31 $0.18B $9.90B 1.70%
2008-12-31 $-0.34B $10.41B -3.02%
2008-09-30 $-1.60B $11.02B -14.11%
2008-06-30 $-1.64B $11.50B -16.81%
2008-03-31 $-1.54B $11.60B -19.31%
2007-12-31 $-1.16B $11.35B -18.96%
2007-09-30 $0.29B $4.48B 7.63%
2007-06-30 $0.22B $4.48B 6.84%
2007-03-31 $0.22B $4.25B 8.32%
2006-09-30 $0.20B $2.04B 10.46%
2006-06-30 $0.16B $1.98B 8.42%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $9.848B $11.434B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $52.193B 9.52
Teva Pharmaceutical Industries (TEVA) Israel $7.654B 3.01
Bausch Health Cos (BHC) Canada $7.481B 4.99
Dr Reddy's Laboratories (RDY) India $5.868B 19.74
ASPEN PHARMACR (APNHY) South Africa $1.894B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.426B 13.94
Amphastar Pharmaceuticals (AMPH) United States $1.048B 51.60
Voyager Therapeutics (VYGR) United States $0.780B 0.00
Homology Medicines (FIXX) United States $0.769B 0.00
CymaBay Therapeutics (CBAY) United States $0.406B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.381B 0.52
Akorn (AKRX) United States $0.350B 0.00
Assembly Biosciences (ASMB) United States $0.321B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.317B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.277B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.172B 0.00
Sol-Gel Technologies (SLGL) Israel $0.160B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.089B 0.00
Teligent (TLGT) United States $0.037B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00